Last reviewed · How we verify
Bupivacaine 25cc
Bupivacaine 25cc is a Small molecule drug developed by Hospital for Special Surgery, New York. It is currently FDA-approved. Also known as: Exparel, Marcaine, Marcaine Spinal (PF).
At a glance
| Generic name | Bupivacaine 25cc |
|---|---|
| Also known as | Exparel, Marcaine, Marcaine Spinal (PF) |
| Sponsor | Hospital for Special Surgery, New York |
| Modality | Small molecule |
| Phase | FDA-approved |
Approved indications
Common side effects
Key clinical trials
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- Bupivacaine 25cc CI brief — competitive landscape report
- Bupivacaine 25cc updates RSS · CI watch RSS
- Hospital for Special Surgery, New York portfolio CI
Frequently asked questions about Bupivacaine 25cc
What is Bupivacaine 25cc?
Bupivacaine 25cc is a Small molecule drug developed by Hospital for Special Surgery, New York.
Who makes Bupivacaine 25cc?
Bupivacaine 25cc is developed and marketed by Hospital for Special Surgery, New York (see full Hospital for Special Surgery, New York pipeline at /company/hospital-for-special-surgery-new-york).
Is Bupivacaine 25cc also known as anything else?
Bupivacaine 25cc is also known as Exparel, Marcaine, Marcaine Spinal (PF).
What development phase is Bupivacaine 25cc in?
Bupivacaine 25cc is FDA-approved (marketed).
Related
- Manufacturer: Hospital for Special Surgery, New York — full pipeline
- Also known as: Exparel, Marcaine, Marcaine Spinal (PF)
- Compare: Bupivacaine 25cc vs similar drugs
- Pricing: Bupivacaine 25cc cost, discount & access